Glycanostics
Bratislava
About Glycanostics
Glycanostics is a start-up company providing an early-stage cancer diagnostic test. They develop clinically validate and register an affordable, non-invasive next-gen liquid biopsy prostate cancer diagnostic test.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $2.4M
- Funding stage: Seed
- Last round: Grant (Jun 2021)
- Website: glycanostics.com
- Phone: +421 915 313 964
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/glycanostics-132744 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.